|
1
|
Akbar SM, Chen S, Al-Mahtab M, Abe M,
Hiasa Y and Onji M: Strong and multi-antigen specific immunity by
hepatitis B core antigen (HBcAg)-based vaccines in a murine model
of chronic hepatitis B: HBcAg is a candidate for a therapeutic
vaccine against hepatitis B virus. Antiviral Res. 96:59–64. 2012.
View Article : Google Scholar
|
|
2
|
Chen W, Shi M, Shi F, Mao Y, Tang Z, Zhang
B, Zhang H, Chen L, Chen L, Xin S and Wang FS: HBcAg-pulsed
dendritic cell vaccine induces Th1 polarization and production of
hepatitis B virus-specific cytotoxic T lymphocytes. Hepatol Res.
39:355–365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen M and Bouvier M: Analysis of
interactions in a tapasin/class I complex provides a mechanism for
peptide selection. EMBO J. 26:1681–1690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim D, Jeon C, Kim JH, Kim MS, Yoon CH,
Choi IS, Kim SH and Bae YS: Cytoplasmic transduction peptide (CTP):
new approach for the delivery of biomolecules into cytoplasm in
vitro and in vivo. Exp Cell Res. 312:1277–1288. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen X, Lai J, Pan Q, Tang Z, Yu Y and
Zang G: The delivery of HBcAg via Tat-PTD enhances specific immune
response and inhibits Hepatitis B virus replication in transgenic
mice. Vaccine. 28:3913–3919. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Liu H, Tang Z, Yu Y and Zang G:
The modification of Tapasin enhances cytotoxic T lymphocyte
activity of intracellular delivered CTL epitopes via cytoplasmic
transduction peptide. Acta Biochim Biophys Sin (Shanghai).
45:203–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Piao RL, Liu YY, Tian D, Ma ZH, Zhang M,
Zhao C and Niu JQ: Adefovir dipivoxil modulates cytokine expression
in Th1/Th2 cells in patients with chronic hepatitis B. Mol Med Rep.
5:184–189. 2012.PubMed/NCBI
|
|
8
|
Bian G, Cheng Y, Wang Z, Hu Y, Zhang X, Wu
M, Chen Z, Shi B, Sun S, Shen Y, Chen EJ, Yao X, Wen Y and Yuan Z:
Whole recombinant Hansenula polymorpha expressing hepatitis B virus
surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and
Th2 immune responses. Vaccine. 28:187–194. 2009. View Article : Google Scholar
|
|
9
|
Han LN, Guo SL, Li TL, Ding GL, Zhang YJ
and Ma JL: Effect of immune modulation therapy on cardiac function
and T-bet/GATA-3 gene expression in aging male patients with
chronic cardiac insufficiency. Immunotherapy. 5:143–153. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
García-Ojeda ME, Klein Wolterink RG,
Lemaître F, Richard-Le Goff O, Hasan M, Hendriks RW, Cumano A and
Di Santo JP: GATA-3 promotes T-cell specification by repressing
B-cell potential in pro-T cells in mice. Blood. 121:1749–1759.
2013.PubMed/NCBI
|
|
11
|
Liu X, Tang Z, Zhang Y, Hu J, Li D, Zang G
and Yu Y: Lentivirally overexpressed T-bet regulates T-helper cell
lineage commitment in chronic hepatitis B patients. Mol Med Rep.
6:361–366. 2012.PubMed/NCBI
|
|
12
|
Masood KI, Rottenberg ME, Salahuddin N,
Irfan M, Rao N, Carow B, Islam M, Hussain R and Hasan Z: Expression
of M. tuberculosis-induced suppressor of cytokine signaling
(SOCS)1, SOCS3, FoxP3 and secretion of IL-6 associates with
differing clinical severity of tuberculosis. BMC Infect Dis.
13:132013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Horino J, Fujimoto M, Terabe F, Serada S,
Takahashi T, Soma Y, Tanaka K, Chinen T, Yoshimura A, Nomura S,
Kawase I, Hayashi N, Kishimoto T and Naka T: Suppressor of cytokine
signaling-1 ameliorates dextran sulfate sodium-induced colitis in
mice. Int Immunol. 20:753–762. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakaya M, Hamano S, Kawasumi M, Yoshida H,
Yoshimura A and Kobayashi T: Aberrant IL-4 production by
SOCS3-over-expressing T cells during infection with Leishmania
major exacerbates disease manifestations. Int Immunol. 23:195–202.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guidotti LG, Matzke B, Schaller H and
Chisari FV: High-level hepatitis B virus replication in transgenic
mice. J Virol. 69:6158–6169. 1995.PubMed/NCBI
|
|
16
|
Wang S, Han Q, Zhang N, Chen J, Liu Z,
Zhang G and Li Z: HBcAg18-27 epitope fused to HIV-Tat 49–57
adjuvanted with CpG ODN induces immunotherapeutic effects in
transgenic mice. Immunol Lett. 127:143–149. 2010.PubMed/NCBI
|
|
17
|
Pei J, Tang Z, Zang G and Yu Y: Blockage
of Notch1 signaling modulates the T-helper (Th) 1/Th2 cell balance
in chronic hepatitis B patients. Hepatol Res. 40:799–805. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grimm D, Heeg M and Thimme R: Hepatitis B
virus: from immunobiology to immunotherapy. Clin Sci (Lond).
124:77–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Asabe S, Wieland SF, Chattopadhyay PK,
Roederer M, Engle RE, Purcell RH and Chisari FV: The size of the
viral inoculum contributes to the outcome of hepatitis B virus
infection. J Virol. 83:9652–9662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu Y, Wu H, Tang Z and Zang G: CTLA4
silencing with siRNA promotes deviation of Th1/Th2 in chronic
hepatitis B patients. Cell Mol Immunol. 6:123–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cakir M, Akcay S, Karakas T, Gedik Y,
Okten A and Orhan F: Prevalence of atopy in children with type 1
diabetes mellitus, hepatitis B virus carriers, and healthy
children: role of T helper 1 (Th1)-type immune response. Allergy
Asthma Proc. 29:166–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsai SL, Sheen IS, Chien RN, Chu CM, Huang
HC, Chuang YL, Lee TH, Liao SK, Lin CL, Kuo GC and Liaw YF:
Activation of Th1 immunity is a common immune mechanism for the
successful treatment of hepatitis B and C: tetramer assay and
therapeutic implications. J Biomed Sci. 10:120–135. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Boni C, Bertoletti A, Penna A, Cavalli A,
Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R,
Fiaccadori F and Ferrari C: Lamivudine treatment can restore T cell
responsiveness in chronic hepatitis B. J Clin Invest. 102:968–975.
1998. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szkaradkiewicz A, Jopek A, Wysocki J,
Grzymislawski M, Malecka I and Woźniak A: HBcAg-specific cytokine
production by CD4 T lymphocytes of children with acute and chronic
hepatitis B. Virus Res. 97:127–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu J and Paul WE: Peripheral CD4+ T-cell
differentiation regulated by networks of cytokines and
transcription factors. Immunol Rev. 238:247–262. 2010.
|
|
26
|
Afkarian M, Sedy JR, Yang J, Jacobson NG,
Cereb N, Yang SY, Murphy TL and Murphy KM: T-bet is a STAT1-induced
regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol.
3:549–557. 2002.PubMed/NCBI
|
|
27
|
Lighvani AA, Frucht DM, Jankovic D, Yamane
H, Aliberti J, Hissong BD, Nguyen BV, Gadina M, Sher A, Paul WE and
O’Shea JJ: T-bet is rapidly induced by interferon-gamma in lymphoid
and myeloid cells. Proc Natl Acad Sci USA. 98:15137–15142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schulz EG, Mariani L, Radbruch A and Höfer
T: Sequential polarization and imprinting of type 1 T helper
lymphocytes by interferon-gamma and interleukin-12. Immunity.
30:673–683. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Y, Ochando JC, Bromberg JS and Ding
Y: Identification of a distant T-bet enhancer responsive to
IL-12/Stat4 and IFNgamma/Stat1 signals. Blood. 110:2494–2500. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong F, Shen Y, Zhang Q, Sun Y, Tang J,
Tao F and Xu Q: Obaculactone suppresses Th1 effector cell function
through down-regulation of T-bet and prolongs skin graft survival
in mice. Biochem Pharmacol. 80:218–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu Q, Sharma A, Oh SY, Moon HG, Hossain
MZ, Salay TM, Leeds KE, Du H, Wu B, Waterman ML, Zhu Z and Sen JM:
T cell factor 1 initiates the T helper type 2 fate by inducing the
transcription factor GATA-3 and repressing interferon-gamma. Nat
Immunol. 10:992–999. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Daegelmann C, Herberth G, Röder S,
Herbarth O, Giese T, Krämer U, Behrendt H, Borte M, Heinrich J,
Emmrich F and Lehmann I; LISAplus study group. Association between
suppressors of cytokine signalling, T-helper type 1/T-helper type 2
balance and allergic sensitization in children. Clin Exp Allergy.
38:438–448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Babu S, Kumaraswami V and Nutman TB:
Transcriptional control of impaired Th1 responses in patent
lymphatic filariasis by T-box expressed in T cells and suppressor
of cytokine signaling genes. Infect Immun. 73:3394–3401. 2005.
View Article : Google Scholar : PubMed/NCBI
|
